• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Merck & Co (MRK)

Common Stock
Sell: $139.39|Buy: $139.90|Change: 4.76 (-3.30%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. In cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 53% of the company's 2025 sales were generated from US human health (pharmaceuticals and vaccines).

Address

126 East Lincoln Avenue
Rahway
NJ
USA
07065

Telephone

+1 732 594-1468

Website

https://www.merck.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Merck & Co Inc Third Quarter Earnings Conference Call for 20272027-10-28T09:00:00
Merck & Co Inc Third Quarter Earnings Result for 20272027-10-28T00:00:00
Merck & Co Inc Second Quarter Earnings Conference Call for 20272027-08-04T09:00:00
Merck & Co Inc Second Quarter Earnings Result for 20272027-08-04T00:00:00
Merck & Co Inc Annual General Meeting for 20272027-05-26T09:00:00
Merck & Co Inc First Quarter Earnings Conference Call for 20272027-04-29T09:00:00
Merck & Co Inc First Quarter Earnings Result for 20272027-04-29T00:00:00
Merck & Co Inc Annual Report for 20262027-02-24T00:00:00
Merck & Co Inc Fourth Quarter Earnings Conference Call for 20262027-02-02T09:00:00
Merck & Co Inc Fourth Quarter Earnings Result for 20262027-02-02T00:00:00
Merck & Co Inc Third Quarter Earnings Conference Call for 20262026-10-29T09:00:00
Merck & Co Inc Third Quarter Earnings Results for 20262026-10-29T00:00:00

Previous key dates

NameKey Date
Merck & Co Inc Third Quarter Earnings Conference Call for 20262026-10-29T09:00:00
Merck & Co Inc Third Quarter Earnings Results for 20262026-10-29T00:00:00
Morgan Stanley 24th Annual Global Healthcare Conference2026-09-14T15:20:00
Wells Fargo 21st Annual Healthcare Conference2026-09-09T14:15:00
Merck & Co Inc Second Quarter Earnings Conference Call for 20262026-08-04T09:00:00
Merck & Co Inc Second Quarter Earnings Results for 20262026-08-04T00:00:00
Goldman Sachs 47th Annual Global Healthcare Conference2026-06-09T11:20:00
Jefferies Global Healthcare Conference in New York2026-06-04T10:30:00
Oncology Investor Event2026-06-01T18:00:00
Merck & Co Inc Annual General Meeting for 20262026-05-26T09:00:00
Merck & Co Inc First Quarter Earnings Conference Call for 20262026-04-30T09:00:00
Merck & Co Inc First Quarter Earnings Result for 20262026-04-30T00:00:00
Merck to Acquire Terns Pharmaceuticals2026-03-25T08:00:00
TD Cowen 46th Annual Health Care Conference2026-03-03T13:50:00
Merck & Co Inc Annual Report for 20252026-02-24T00:00:00
Merck & Co Inc Fourth Quarter Earnings Conference Call for 20252026-02-03T09:00:00
Merck & Co Inc Fourth Quarter Earnings Results for 20252026-02-03T00:00:00
44th Annual J.P. Morgan Healthcare Conference2026-01-12T19:30:00
Citi 2025 Global Healthcare Conference2025-12-03T13:00:00
8th Annual Evercore ISI HealthCONx Conference2025-12-02T09:10:00
Jefferies Global Healthcare Conference2025-11-20T09:30:00
Merck & Co Inc Third Quarter Earnings Conference Call for 20252025-10-30T09:00:00
Merck & Co Inc Third Quarter Earnings Result for 20252025-10-30T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.